APA

Marcucci G., Byrd J. C., Dai G., Klisovic M. I., Kourlas P. J., Young D. C., Cataland S. R., Fisher D. B., Lucas D., Chan K. K., Porcu P., Lin Z., Farag S. F., Frankel S. R., Zwiebel J. A., Kraut E. H., Balcerzak S. P., Bloomfield C. D., Grever M. R. & Caligiuri M. A. (20030408). Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia. : Blood.

Chicago

Marcucci Guido, Byrd John C, Dai Guowei, Klisovic Marko I, Kourlas Peter J, Young Donn C, Cataland Spero R, Fisher Diane B, Lucas David, Chan Kenneth K, Porcu Pierluigi, Lin Zhong-Pin, Farag Sherif F, Frankel Stanley R, Zwiebel James A, Kraut Eric H, Balcerzak Stanley P, Bloomfield Clara D, Grever Michael R and Caligiuri Michael A. 20030408. Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia. : Blood.

Harvard

Marcucci G., Byrd J. C., Dai G., Klisovic M. I., Kourlas P. J., Young D. C., Cataland S. R., Fisher D. B., Lucas D., Chan K. K., Porcu P., Lin Z., Farag S. F., Frankel S. R., Zwiebel J. A., Kraut E. H., Balcerzak S. P., Bloomfield C. D., Grever M. R. and Caligiuri M. A. (20030408). Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia. : Blood.

MLA

Marcucci Guido, Byrd John C, Dai Guowei, Klisovic Marko I, Kourlas Peter J, Young Donn C, Cataland Spero R, Fisher Diane B, Lucas David, Chan Kenneth K, Porcu Pierluigi, Lin Zhong-Pin, Farag Sherif F, Frankel Stanley R, Zwiebel James A, Kraut Eric H, Balcerzak Stanley P, Bloomfield Clara D, Grever Michael R and Caligiuri Michael A. Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia. : Blood. 20030408.